{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T19:40:58Z","timestamp":1794598858238,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005407","name":"Hong Kong Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhep.2026.06.029","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:33:34Z","timestamp":1782516814000},"page":"843-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HbA1c trajectories and the risk of liver-related events in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1283-5355","authenticated-orcid":false,"given":"Nana","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherlot Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5749-1598","authenticated-orcid":false,"given":"Jimmy Che-To","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-9389","authenticated-orcid":false,"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-9410","authenticated-orcid":false,"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1819-2464","authenticated-orcid":false,"given":"Terry Cheuk-Fung","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.06.029_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"The Lancet"},{"key":"10.1016\/j.jhep.2026.06.029_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.32774","article-title":"Geographical similarity and differences in the burden and genetic predisposition of NAFLD","volume":"77","author":"Yip","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib4","first-page":"1999","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2026.06.029_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis","volume":"8","author":"Huang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.06.029_bib6","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HEP.0000000000000432","article-title":"Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: a landmark analysis","volume":"78","author":"Zhang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib7","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.cgh.2019.04.038","article-title":"Risk factors for severe liver disease in patients with type 2 diabetes","volume":"17","author":"Bj\u00f6rkstr\u00f6m","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.06.029_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.32716","article-title":"Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes","volume":"77","author":"Mak","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.31806","article-title":"Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease","volume":"74","author":"Alexopoulos","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4093\/dmj.2023.0200","article-title":"Glycemic control is associated with histological findings of nonalcoholic fatty liver disease","volume":"48","author":"Miyake","year":"2024","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jhep.2026.06.029_bib11","article-title":"Long-term glycemic control and the risk of liver stiffness progression and liver-related events in MASLD","author":"Zhou","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.06.029_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.numecd.2022.12.010","article-title":"Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent","volume":"33","author":"Colosimo","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhep.2026.06.029_bib13","unstructured":"The Hospital Authority. Hospital authority statistical report 2023-2024. https:\/\/www3.ha.org.hk\/data\/HAStatistics\/StatisticalReport\/2023-2024 (Assessed 6 November 2025)."},{"key":"10.1016\/j.jhep.2026.06.029_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jhep.2023.12.001","article-title":"Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B","volume":"80","author":"Yip","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.06.029_bib15","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1038\/s41467-024-48007-8","article-title":"Individualized prevention of proton pump inhibitor related adverse events by risk stratification","volume":"15","author":"Xia","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.06.029_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ejhf.455","article-title":"Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study","volume":"18","author":"Elder","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhep.2026.06.029_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cgh.2017.12.009","article-title":"Effects of diabetes and glycemic control on risk of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen","volume":"16","author":"Yip","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.06.029_bib18","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.32244","article-title":"Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease","volume":"75","author":"Kramer","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib19","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2026.06.029_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neucom.2023.01.043","article-title":"PDBI: a partitioning Davies-Bouldin index for clustering evaluation","volume":"528","author":"Ros","year":"2023","journal-title":"Neurocomputing"},{"key":"10.1016\/j.jhep.2026.06.029_bib21","series-title":"2020 IEEE 7th Int. Conf. Data Sci. Adv. Anal. DSAA","first-page":"747","article-title":"Cluster quality analysis using silhouette score","author":"Shahapure","year":"2020"},{"key":"10.1016\/j.jhep.2026.06.029_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03610927408827101","article-title":"A dendrite method for cluster analysis","volume":"3","author":"Cali\u0144ski","year":"1974","journal-title":"Commun Stat"},{"key":"10.1016\/j.jhep.2026.06.029_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10115-023-01952-0","article-title":"A review and evaluation of elastic distance functions for time series clustering","volume":"66","author":"Holder","year":"2024","journal-title":"Knowl Inf Syst"},{"key":"10.1016\/j.jhep.2026.06.029_bib24","first-page":"928A","article-title":"Accuracy of administrative coding for nonalcoholic fatty liver disease and related hepatic complications: a single-center validation study","volume":"74","author":"Yip","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies","volume":"20","author":"Schisterman","year":"2009","journal-title":"Epidemiol"},{"key":"10.1016\/j.jhep.2026.06.029_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41424-018-0053-0","article-title":"Association between type 2 diabetes mellitus, HbA1c and the risk for spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis and ascites","volume":"9","author":"Tergast","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2026.06.029_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/HEP.0000000000000837","article-title":"Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study","volume":"80","author":"Chung","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.029_bib28","first-page":"S86","article-title":"5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2026.06.029_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S2213-8587(21)00245-X","article-title":"Glycaemic management in diabetes: old and new approaches","volume":"10","author":"Ceriello","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jhep.2026.06.029_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imcb.12297","article-title":"Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK\/mTOR-mediated autophagy induction","volume":"98","author":"Wang","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jhep.2026.06.029_bib31","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.3390\/ijms24119352","article-title":"Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections","volume":"24","author":"Gonz\u00e1lez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2026.06.029_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011128","article-title":"The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease","volume":"22","author":"Ziolkowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2026.06.029_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.21037\/atm-20-1839","article-title":"Diabetes induces hepatocyte pyroptosis by promoting oxidative stress-mediated NLRP3 inflammasome activation during liver ischaemia and reperfusion injury","volume":"8","author":"Shi","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jhep.2026.06.029_bib34","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.2337\/dc19-0848","article-title":"Variability in glycated hemoglobin and risk of poor outcomes among people with type 2 diabetes in a large primary care cohort study","volume":"42","author":"Critchley","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2026.06.029_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(24)00537-3","article-title":"Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)","volume":"404","author":"Adler","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.jhep.2026.06.029_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2026.06.029_bib37","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2026.06.029_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-01755-x","article-title":"Metabolic memory: mechanisms and diseases","volume":"9","author":"Dong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2026.06.029_bib39","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0168-8227(09)70002-6","article-title":"Hypothesis: the \u201cmetabolic memory\u201d, the new challenge of diabetes","volume":"86","author":"Ceriello","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jhep.2026.06.029_bib40","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00125-021-05539-8","article-title":"The legacy effect in diabetes: are there long-term benefits?","volume":"64","author":"Folz","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2026.06.029_bib41","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1530\/JME-19-0170","article-title":"Epigenetic regulation in diabetic vascular complications","volume":"63","author":"Jin","year":"2019","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jhep.2026.06.029_bib42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/jvh.13307","article-title":"Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B","volume":"27","author":"Yip","year":"2020","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2026.06.029_bib43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gutjnl-2024-332687","article-title":"Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease","volume":"74","author":"Bea","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.06.029_bib44","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamainternmed.2024.4661","article-title":"GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease","volume":"184","author":"Kanwal","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhep.2026.06.029_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.06.029_bib46","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826026620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826026620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:59:22Z","timestamp":1792083562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826026620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0168827826026620"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.06.029","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HbA1c trajectories and the risk of liver-related events in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}